Departamento de Ciencias y Tecnologia Farmaceuticas, Facultad de Ciencias Quimicas y Farmaceuticas, Universidad de Chile, Santiago de Chile, Chile.
Curr Pharm Des. 2019;25(4):455-466. doi: 10.2174/1381612825666190404121507.
The first limiting barrier for the transport in the skin is the stratum corneum; different strategies have been developed to overcome this barrier, including chemical enhancers. However, these penetration enhancers have limitations, including toxic adverse effects. In this context, research into nanomaterials has provided new tools to increase the residence time of drugs by generating a reservoir, increasing the specificity of drugs and reducing their adverse effects, and improving the penetration of drugs that are difficult to formulate. Silica nanoparticles have been proposed as suitable nanocarriers for skin delivery. Unfortunately, the mechanisms involved in the interaction, transport and fate of silica nanoparticles in the skin have not been fully investigated. This paper reviews significant findings about the interaction between silica-based nanocarriers and the skin. First, this review focuses on the properties and functions of the skin, the skin penetration properties of silica nanoparticles, their synthesis strategies and their toxicity. Finally, advances and evidence on the application of silica nanocarriers in skin drug delivery are provided, in which the use of nanoparticles increases the stability and solubility of the bioactive compound, enhancing its performance, act as penetrator enhancer and improving controlled release. Thus, improving the treatment of some skin disorders.
在皮肤中运输的第一个限制屏障是角质层;已经开发了不同的策略来克服这一障碍,包括化学增强剂。然而,这些渗透增强剂有其局限性,包括毒性的不良影响。在这种情况下,对纳米材料的研究为通过产生储库来增加药物的滞留时间、增加药物的特异性和减少其副作用以及改善难以配方的药物的渗透提供了新的工具。二氧化硅纳米颗粒已被提议作为适合皮肤给药的纳米载体。不幸的是,二氧化硅纳米颗粒在皮肤中的相互作用、运输和命运的机制尚未得到充分研究。本文综述了关于基于二氧化硅的纳米载体与皮肤相互作用的重要发现。首先,本综述重点介绍了皮肤的特性和功能、二氧化硅纳米颗粒的皮肤穿透特性、它们的合成策略及其毒性。最后,提供了关于二氧化硅纳米载体在皮肤药物输送中的应用的进展和证据,其中纳米颗粒的使用增加了生物活性化合物的稳定性和溶解度,增强了其性能,充当渗透增强剂并改善了控制释放。因此,改善了一些皮肤疾病的治疗效果。